Syndax Pharmaceuticals Inc
SNDX
DELAYED 1 MONTH

2 insider filings · Latest: Jun 1, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Jun 1, 2026Jun 2 8:30 PMKeith A. GoldanChief Financial Officer
Sale
1,177$18.99$22.4K139,252(D)

View →

Jun 1, 2026Jun 2 8:30 PMMichael A MetzgerDirector, Chief Executive Officer
Sale
6,847$18.99$130.0K484,843(D)

View →

Stock Options & Derivatives

No transactions found.